Shi J, Hu C, Zhou Y, Cui C, Yang J, Cui Q
Mol Ther Nucleic Acids. 2020; 21:687-695.
PMID: 32769059
PMC: 7347495.
DOI: 10.1016/j.omtn.2020.07.006.
Gao R, Mitra R, Zheng M, Wang K, Dahringer J, Han Z
Adv Funct Mater. 2020; 28(52).
PMID: 32699541
PMC: 7375362.
DOI: 10.1002/adfm.201806248.
Martinez-Sanchez M, Moctezuma-Davila M, Hernandez-Monge J, Rangel-Charqueno M, Olivares-Illana V
PLoS One. 2020; 15(6):e0234337.
PMID: 32502182
PMC: 7274427.
DOI: 10.1371/journal.pone.0234337.
Liu K, Liu Y, Zhao G
Int J Clin Exp Pathol. 2020; 10(9):9352-9361.
PMID: 31966807
PMC: 6965960.
Wu Q, Sun X, Zheng G
Medicine (Baltimore). 2018; 97(51):e13753.
PMID: 30572521
PMC: 6319877.
DOI: 10.1097/MD.0000000000013753.
Loss of p53 suppresses replication-stress-induced DNA breakage in G1/S checkpoint deficient cells.
Benedict B, van Harn T, Dekker M, Hermsen S, Kucukosmanoglu A, Pieters W
Elife. 2018; 7.
PMID: 30322449
PMC: 6221544.
DOI: 10.7554/eLife.37868.
CRISPR/Cas9 mediated knockout of rb1 and rbl1 leads to rapid and penetrant retinoblastoma development in Xenopus tropicalis.
Naert T, Colpaert R, Van Nieuwenhuysen T, Dimitrakopoulou D, Leoen J, Haustraete J
Sci Rep. 2016; 6:35264.
PMID: 27739525
PMC: 5064383.
DOI: 10.1038/srep35264.
Lessons from Retinoblastoma: Implications for Cancer, Development, Evolution, and Regenerative Medicine.
Dyer M
Trends Mol Med. 2016; 22(10):863-876.
PMID: 27567287
PMC: 5048577.
DOI: 10.1016/j.molmed.2016.07.010.
Establishment of an Orthotopic Xenograft Mice Model of Retinoblastoma Suitable for Preclinical Testing.
Cassoux N, Thuleau A, Assayag F, Aerts I, Decaudin D
Ocul Oncol Pathol. 2016; 1(3):200-6.
PMID: 27171982
PMC: 4847680.
DOI: 10.1159/000370156.
Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma.
Pritchard E, Dyer M, Guy R
Mini Rev Med Chem. 2015; 16(6):430-54.
PMID: 26202204
PMC: 5509337.
DOI: 10.2174/1389557515666150722100610.
Management of retinoblastoma in children: current status.
Chantada G, Schaiquevich P
Paediatr Drugs. 2015; 17(3):185-98.
PMID: 25742925
DOI: 10.1007/s40272-015-0121-9.
Immunohistochemical expression of CD117 and vascular endothelial growth factor in retinoblastoma: possible targets of new therapies.
Youssef N, Said A
Int J Clin Exp Pathol. 2014; 7(9):5725-37.
PMID: 25337214
PMC: 4203185.
Aberrant activation of p53 due to loss of MDM2 or MDMX causes early lens dysmorphogenesis.
Zhang Y, Zhang X, Lu H
Dev Biol. 2014; 396(1):19-30.
PMID: 25263199
PMC: 5393629.
DOI: 10.1016/j.ydbio.2014.09.017.
Multimodality imaging methods for assessing retinoblastoma orthotopic xenograft growth and development.
Corson T, Samuels B, Wenzel A, Geary A, Riley A, McCarthy B
PLoS One. 2014; 9(6):e99036.
PMID: 24901248
PMC: 4047070.
DOI: 10.1371/journal.pone.0099036.
Animal models in retinoblastoma research.
Nair R, Kaliki S, Vemuganti G
Saudi J Ophthalmol. 2013; 27(3):141-6.
PMID: 24227978
PMC: 3770224.
DOI: 10.1016/j.sjopt.2013.06.008.
Orthotopic transplantation of retinoblastoma cells into vitreous cavity of zebrafish for screening of anticancer drugs.
Jo D, Son D, Na Y, Jang M, Choi J, Kim J
Mol Cancer. 2013; 12:71.
PMID: 23835085
PMC: 3707771.
DOI: 10.1186/1476-4598-12-71.
Of mice and men: fuzzy tandem repeats and divergent p53 transcriptional repertoires.
Morin A, Bardot B, Simeonova I, Lejour V, Bouarich-Bourimi R, Toledo F
Transcription. 2013; 4(2):67-71.
PMID: 23412358
PMC: 3646056.
DOI: 10.4161/trns.23772.
Molecular deregulation induced by silencing of the high mobility group protein A2 gene in retinoblastoma cells.
Venkatesan N, Krishnakumar S, Deepa P, Deepa M, Khetan V, Reddy M
Mol Vis. 2012; 18:2420-37.
PMID: 23077401
PMC: 3472926.
Analysis of MDM2 and MDM4 single nucleotide polymorphisms, mRNA splicing and protein expression in retinoblastoma.
McEvoy J, Ulyanov A, Brennan R, Wu G, Pounds S, Zhang J
PLoS One. 2012; 7(8):e42739.
PMID: 22916154
PMC: 3423419.
DOI: 10.1371/journal.pone.0042739.
Fuzzy tandem repeats containing p53 response elements may define species-specific p53 target genes.
Simeonova I, Lejour V, Bardot B, Bouarich-Bourimi R, Morin A, Fang M
PLoS Genet. 2012; 8(6):e1002731.
PMID: 22761580
PMC: 3386156.
DOI: 10.1371/journal.pgen.1002731.